$DXCM

AI Analysis

Generated on May 11, 2026

AI Score
66/ 100
Hold$DXCM

DexCom Inc.

$DXCMNASDAQHealthcareLarge-Cap

Dexcom develops and markets continuous glucose monitoring systems for diabetes management.

Market Cap
$32.0B
Revenue (TTM)
$3.9B
+12.0%
Net Income (TTM)
$0.5B
+20.0%
EPS (TTM)
$1.25
P/E Ratio
80.0
Dividend Yield
0.0%
52-Week Range
$62-$140
Beta
1.15
Dimension Scores
Fundamental
62
Technical
58
Sentiment
68
Risk / Reward
60
Momentum
68
FundTechSentRiskMome
Financial Health
Profitability
67moderate
Growth
71moderate
Liquidity
68strong
Solvency
64strong
Efficiency
60moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $DXCM

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.